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WHICH HORMONES HAVE BEEN TESTED?
PRELIMINARY RESULTS
FUTURE WORK
As a continuation of this project we will test  additional hormones on micro-
bial communities from additional donors. We will test the combinatorial ef-
fects of  estrogen and progestins when dosed simulataneously. Several 
presciption formulations of oral contraceptives contain iron in the form of 
ferrous fumarate. Further investigation into the role of iron in combination 
with contraceptive hormones will be addressed. Addtitionally, we will assess 
whether prodrugs have the same effect on taxon abundance and diversity as 
activated drugs and if we can chemically detect their presence. 
ABSTRACT
The effect of pharmaceuticals, including hormone-based contraceptives, on gut mi-
crobiota is both unclear and understudied. Our goal is to evaluate the bidirectional 
interactions between these drugs and gut microbiota. Specifically, we hypothesize 
that hormones influence the structure and function of gut microbial communities. 
Secondly, we predict that microbial community members can metabolize the con-
traceptive hormones administered in the most common prescriptions. Many proges-
tins used in hormonal contraceptives are prodrugs that have to be metabolically acti-
vated by hepatic cytochromes P450s for activation. Along with the interactions of 
all the hormones and the gut microbiome, we aim to determine the capacity of gut 
microbiota to activate these prodrugs and whether the gut metagenome might 
encode microbial pathways that provide an alternative source of prodrug activation, 
something that is unknown at this point. In this study we use an in vitro culture 
system exposing gut microbiota to the most common hormones used in hormonal 
contraceptives. 16S rRNA gene amplification and sequencing will be used to deter-
mine the taxonomic effects of the hormones on the microbial communities. Func-
tional assessment will be executed using metagenome prediction. Our preliminary 
data show changes in taxon abundances and diversity in the presence of hormones. 
Future work we will include chemical analysis of the hormone prodrugs and active 
metabolites from microbial communities exposed to only the prodrug.
This in-process project will provide information to the research community on the 
role of gut bacterial communities in women relying on orally delivered hormones 
for contraceptive or health purposes. It will also shed light on the potential that these 
bacterial communities might be influencing the metabolism of progestin prodrugs, 
something not currently known.
SAMPLE PREPARATION
Uncovering interactions between oral hormone 
contraceptives and human gut microbiota 
Burns Lab
www.burns-lab.orgAnnemiek Doedens, Jessie Chen, Sri Contractor, Sidra Sohail and Michael B. Burns, PhD
Loyola University Chicago, Department of Biology
Healthy
donor
Fresh collection Sample preparation carried out in 
Coy anaerobic chamber, on ice
Sample 
homogenized 
in buffer
Bulk material 
removed Cryoprotectant added, aliquotted, and frozen 
RESEARCH GOAL
Determine whether contraceptive hormones have an 
effect on bacterial community structure in the gut.
EXPERIMENTAL WORKFLOW
Acetomitophen NAPQI
N-acetyl-p-benzoquinone imine
Microbial community is thawed and split 
across multiple culture tubes in Coy chamber 
(1) Contamination control
(2) Negative control
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(4) 0.1x concentration
(5) 1x concentration
(6) 10x concentration
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The only significant changes found in alpha 
diversity plots were due to passage  of time, 
but not as a function of hormone exposure. 
However, in beta diversity plots a shift can 
be observed away from the control repli-
cates, indicating the presence of hormone 
has an  effect. Beta  diversity plots for all 
hormones at 24 and 72 hours are shown 
below, and a plot for levonorgestrel at 72 
hours is shown above.  
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The taxon abundance plots show an initial decrease 
in Proteobacteria at the 24 hour timepoint, followed 
by an increase of growth at the 72 hour timepoint. 
Proteobacteria is present in the original microbial 
communities used for culturing as is shown in the 
figure on the left. 
